EICHOR
● Completed
Clesrovimab (MK-1654) in Infants and Children at Increased Risk for Severe Respiratory Syncytial Virus (RSV) Disease (MK-1654-007)
Condition: RSV Infection · Sponsor: Merck Sharp & Dohme LLC
About this study
This study aims to evaluate the safety and tolerability of clesrovimab compared to palivizumab as assessed by the proportion of participants experiencing adverse events (AEs).
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (146)
| Miller Children's & Women's Hospital Long Beach ( Site 0001) | Long Beach, California, United States | — |
| Children's Hospital of Orange County ( Site 0047) | Orange, California, United States | — |
| Children's Hospital Colorado ( Site 0011) | Aurora, Colorado, United States | — |
| Children's National Medical Center ( Site 0020) | Washington D.C., District of Columbia, United States | — |
| Orlando Health - Arnold Palmer Hospital-Orlando Health-Arnold Palmer Hospital Pulmonary and Sleep M ( Site 0022) | Orlando, Florida, United States | — |
| Nemours Children's Health, Lake Nona Medical City ( Site 0032) | Orlando, Florida, United States | — |
| University of South Florida-Department of Pediatrics ( Site 0045) | Tampa, Florida, United States | — |
| Morehouse School Of Medicine ( Site 0049) | Atlanta, Georgia, United States | — |
| Clinical Research Prime ( Site 0046) | Idaho Falls, Idaho, United States | — |
| University of Kentucky HealthCare - Turfland ( Site 0044) | Lexington, Kentucky, United States | — |
| Our Lady of the Lake Children's Hospital ( Site 0031) | Baton Rouge, Louisiana, United States | — |
| Tulane University School of Medicine ( Site 0010) | New Orleans, Louisiana, United States | — |
+ 134 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04938830